keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 20,500 | |||
2 mg | 在庫あり | ¥ 30,500 | |||
5 mg | 在庫あり | ¥ 57,000 | |||
10 mg | 在庫あり | ¥ 91,500 | |||
25 mg | 在庫あり | ¥ 150,000 | |||
50 mg | 在庫あり | ¥ 209,500 | |||
100 mg | お問い合わせ | ¥ 282,500 |
説明 | Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin. |
別名 | SQ19844, CCK-8, Cholecystokinin octapeptide |
分子量 | 1143.27 |
分子式 | C49H62N10O16S3 |
CAS No. | 25126-32-3 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMF: 50 mg/mL (43.73 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sincalide 25126-32-3 Others PI3K/Akt cardiovascular hormone Inhibitor PI3K CCK8 Akt SQ-19844 Protein kinase B Apoptosis inflammation CCK Cholecystokinin Receptor CK‐8 SQ19844 SQ 19844 PKB CCK-8 postevacuation cholecystography Cholecystokinin octapeptide CCK Receptor inhibit CCK 8 Phosphoinositide 3-kinase inhibitor